marketing authorisation - Robuta Search

https://www.jnj.com/media-center/press-releases/janssen-submits-european-marketing-authorisation-application-for-canagliflozin-in-type-2-diabetes Janssen Submits European Marketing Authorisation Application for Canagliflozin in Type 2 Diabetes marketing authorisation https://www.gov.uk/government/collections/transfer-ownership-of-a-marketing-authorisation Transfer ownership of a marketing authorisation for medicines - GOV.UK How to transfer the ownership of a marketing authorisation including the form you need to complete. transfer ownership marketing authorisation medicines uk https://www.gsk.com/en-gb/media/press-releases/european-medicines-agency-accepts-marketing-authorisation-application-for-momelotinib-for-the-treatment-of-myelofibrosis/ European Medicines Agency accepts marketing authorisation application for momelotinib for the... Application includes data from key phase III trials, including the pivotal MOMENTUM trial. european medicines agency marketing authorisation accepts application https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-submits-european-marketing-authorisation-application-for-pazopanib-in-advanced-kidney-cancer/ GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced... GSK announced submission of MAA to EMEA for pazopanib, oral therapy for metastatic renal cell carcinoma (RCC). marketing authorisation glaxosmithkline submits european application https://www.biospace.com/averoa-submits-marketing-authorisation-application-to-the-european-medicines-agency-seeking-approval-of-ava1014-for-treating-complications-associated-with-chronic-kidney-disease AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking... Apr 24, 2024 - Averoa announces the submission of a marketing authorisation application to the European Medicines Agency for Ferric Citrate Coordination Complex, an oral... european medicines agency marketing authorisation to the submits application https://www.gsk.com/en-gb/media/press-releases/european-medicines-agency-ema-accepts-marketing-authorisation-application-for-daprodustat/ European Medicines Agency (EMA) accepts marketing authorisation application for daprodustat | GSK The EMA has validated the MAA for daprodustat, for the treatment of patients with anaemia of chronic kidney disease. european medicines agency marketing authorisation ema accepts https://investingnews.com/eisai-and-nuvation-bio-announce-marketing-authorisation-application-for-taletrectinib-for-the-treatment-of-advanced-ros1-positive-non-small-cell-lung-cancer-validated-by-the-european-medicines-agency/ Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the... Mar 26, 2026 - The Marketing Authorisation Application (MAA) has been validated and accepted for full approval consideration with a standard review timelineAdditional filings... marketing authorisation eisai bio announce https://www.esmo.org/oncology-news/ema-recommends-granting-a-marketing-authorisation-for-lurbinectedin EMA Recommends Granting a Marketing Authorisation for Lurbinectedin | ESMO marketing authorisation ema recommends granting esmo https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-eu-marketing-authorisation-for-the-first-ever-dispersible-tablet-formulation-of-dolutegravir-tivicay-a-treatment-for-children-living-with-hiv-in-europe/ ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet... The EU Marketing Authorisation follows the US Food and Drug Administration (FDA) approval of Tivicay PD in 2020. viiv healthcare marketing authorisation https://www.gov.uk/government/publications/medicines-marketing-authorisation-change-of-ownership-application Medicines marketing authorisation: change of ownership application - GOV.UK Use this form to transfer a product licence, also known as a marketing authorisation, to a different owner. change of ownership marketing authorisation medicines application uk https://www.gov.uk/guidance/apply-to-change-a-veterinary-marketing-authorisation-or-homeopathic-remedy Apply to change a veterinary Marketing Authorisation or Homeopathic Remedy - GOV.UK Guidance for the pharmaceutical industry on how to apply to vary a veterinary Marketing Authorisation (MA) or Homeopathic Remedy. apply to veterinary marketing https://www.jnj.com/media-center/press-releases/janssen-submits-marketing-authorisation-application-to-the-european-medicines-agency-seeking-approval-of-lazertinib-in-combination-with-rybrevant-amivantamab-for-the-first-line-treatment-of-patients-with-egfr-mutated-non-small-cell-lung-cancer Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking... Nov 30, 2025 - The submission is supported by data from the Phase 3 MARIPOSA study, which featured in a Late-Breaking Presidential Symposium session at the 2023 ESMO... european medicines agency marketing authorisation to the janssen submits https://www.jnj.com/media-center/press-releases/janssen-submits-marketing-authorisationapplication-to-the-european-medicines-agency-seeking-approval-of-erdafitinib-for-the-treatment-of-patients-with-locallyadvanced-or-metastatic-urothelial-cancer-with-susceptible-fgfr-alterations Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking... Nov 30, 2025 - Pending approval, erdafitinib, an investigational, once-daily oral pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor,1will become the... european medicines agency marketing authorisation to the janssen submits https://www.prnewswire.co.uk/news-releases/thrombogenics-announces-ema-acceptance-for-review-of-marketing-authorisation-application-for-ocriplasmin-144765755.html ThromboGenics Announces EMA Acceptance for Review of Marketing Authorisation Application for... /PRNewswire/ -- If Approved, Ocriplasmin Will be the First Pharmacological Treatment for Symptomatic Vitreomacular Adhesion (VMA) Including Macular Hole... for review marketing authorisation announces ema acceptance https://www.esmo.org/oncology-news/ema-recommends-granting-a-marketing-authorisation-for-tarlatamab EMA Recommends Granting a Marketing Authorisation for Tarlatamab | ESMO marketing authorisation ema recommends granting esmo